Annex

United Kingdom

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘fluazuron’ is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRLs Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification
‘Fluazuron Fluazuron All ruminants except bovine and ovine 200 μg/kg Muscle Not for use in animals from which milk is produced for human consumption Antiparasitic agents/Agents (acting) against ectoparasites’
7 000 μg/kg Fat
500 μg/kg Liver
500 μg/kg Kidney
Bovine 200 μg/kg Muscle NO ENTRY
7 000 μg/kg Fat
500 μg/kg Liver
500 μg/kg Kidney
200 μg/kg Milk
Fin fish 200 μg/kg Muscle and skin in natural proportions NO ENTRY

Pharmacologically active Substance	Marker residue	Animal Species	MRLs	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic Classification
‘Fluazuron	Fluazuron	All ruminants except bovine and ovine	200 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption	Antiparasitic agents/Agents (acting) against ectoparasites’
			7 000 μg/kg	Fat
			500 μg/kg	Liver
			500 μg/kg	Kidney
		Bovine	200 μg/kg	Muscle	NO ENTRY
			7 000 μg/kg	Fat
			500 μg/kg	Liver
			500 μg/kg	Kidney
			200 μg/kg	Milk
		Fin fish	200 μg/kg	Muscle and skin in natural proportions	NO ENTRY